Brian Leinwand provides strategic health economics support throughout a product’s life-cycle and helps clients build evidence packages that demonstrate and support the value of their products.
Brian’s area of specialization is economic modeling, and he has developed models to determine the cost-effectiveness and budget impact of medications and medical devices in a range of therapeutic classes. Brian also supports HEOR focused market access activities, such as conducting evidentiary landscape and gap assessments, as well as mapping out and executing on evidence generation strategies to support and strengthen products' value propositions.
Additionally, Brian supports clients in advance of, during, and following formal external third-party value assessments to: 1) provide quantitative support in developing or validating comparative effectiveness and cost-effectiveness analyses; and 2) develop strategies aimed at accurately characterizing and articulating their products’ value and optimally positioning them in the healthcare marketplace.
Prior to joining Avalere, Brian served as a research assistant, at both the University of North Carolina at Chapel Hill and GlaxoSmithKline, and as a health services researcher at Community Care of North Carolina.
Brian has PhD in pharmaceutical outcomes and policy, an MPH in health policy and management, and a BA in management and society from the University of North Carolina at Chapel Hill.